Visine

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 9114 Experts worldwide ranked by ideXlab platform

Claus Cursiefen - One of the best experts on this subject based on the ideXlab platform.

  • prospective randomized controlled comparison of systane ud eye drops versus Visine intensiv 1 edo eye drops for the treatment of moderate dry eye
    Journal of Ocular Pharmacology and Therapeutics, 2012
    Co-Authors: C. Jacobi, Friedrich E. Kruse, Claus Cursiefen
    Abstract:

    Abstract Purpose: The aim of this prospective, randomized, clinical, single-center study was to compare the safety and efficacy of 2 ocular surface lubricant eye drops: preservative-free hydroxypropyl (HP)-Guar (SYSTANE UD®) eye drops versus preservative-free Tamarindus indica seed polysaccharide (TSP) 1% (Visine INTENSIV 1% EDO®) eye drops. Methods: Fifty-six eyes of 28 patients with moderate keratoconjunctivitis sicca (DEWS severity level 2) were enrolled in the trial. Patients were randomized for 2 treatment groups (SYSTANE UD eye drops vs. Visine INTENSIV 1% EDO eye drops). The eye drops in both groups were applied 5 times per day for 3 months. Statistical analyses were performed using Statistica™ software (Mann–Whitney U-test and Wilcoxon test). P-Values<0.05 were considered significant. Results: After 3 months of treatment the patients of both groups had subjective benefit in the relief of symptoms of dry eye disease evaluated by the Ocular Surface Disease Index (OSDI) questionnaire score. Patients ...

  • Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus Visine INTENSIV 1% EDO eye drops for the treatment of moderate dry eye.
    Journal of Ocular Pharmacology and Therapeutics, 2012
    Co-Authors: C. Jacobi, Friedrich E. Kruse, Claus Cursiefen
    Abstract:

    Abstract Purpose: The aim of this prospective, randomized, clinical, single-center study was to compare the safety and efficacy of 2 ocular surface lubricant eye drops: preservative-free hydroxypropyl (HP)-Guar (SYSTANE UD®) eye drops versus preservative-free Tamarindus indica seed polysaccharide (TSP) 1% (Visine INTENSIV 1% EDO®) eye drops. Methods: Fifty-six eyes of 28 patients with moderate keratoconjunctivitis sicca (DEWS severity level 2) were enrolled in the trial. Patients were randomized for 2 treatment groups (SYSTANE UD eye drops vs. Visine INTENSIV 1% EDO eye drops). The eye drops in both groups were applied 5 times per day for 3 months. Statistical analyses were performed using Statistica™ software (Mann–Whitney U-test and Wilcoxon test). P-Values

C. Jacobi - One of the best experts on this subject based on the ideXlab platform.

  • prospective randomized controlled comparison of systane ud eye drops versus Visine intensiv 1 edo eye drops for the treatment of moderate dry eye
    Journal of Ocular Pharmacology and Therapeutics, 2012
    Co-Authors: C. Jacobi, Friedrich E. Kruse, Claus Cursiefen
    Abstract:

    Abstract Purpose: The aim of this prospective, randomized, clinical, single-center study was to compare the safety and efficacy of 2 ocular surface lubricant eye drops: preservative-free hydroxypropyl (HP)-Guar (SYSTANE UD®) eye drops versus preservative-free Tamarindus indica seed polysaccharide (TSP) 1% (Visine INTENSIV 1% EDO®) eye drops. Methods: Fifty-six eyes of 28 patients with moderate keratoconjunctivitis sicca (DEWS severity level 2) were enrolled in the trial. Patients were randomized for 2 treatment groups (SYSTANE UD eye drops vs. Visine INTENSIV 1% EDO eye drops). The eye drops in both groups were applied 5 times per day for 3 months. Statistical analyses were performed using Statistica™ software (Mann–Whitney U-test and Wilcoxon test). P-Values<0.05 were considered significant. Results: After 3 months of treatment the patients of both groups had subjective benefit in the relief of symptoms of dry eye disease evaluated by the Ocular Surface Disease Index (OSDI) questionnaire score. Patients ...

  • Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus Visine INTENSIV 1% EDO eye drops for the treatment of moderate dry eye.
    Journal of Ocular Pharmacology and Therapeutics, 2012
    Co-Authors: C. Jacobi, Friedrich E. Kruse, Claus Cursiefen
    Abstract:

    Abstract Purpose: The aim of this prospective, randomized, clinical, single-center study was to compare the safety and efficacy of 2 ocular surface lubricant eye drops: preservative-free hydroxypropyl (HP)-Guar (SYSTANE UD®) eye drops versus preservative-free Tamarindus indica seed polysaccharide (TSP) 1% (Visine INTENSIV 1% EDO®) eye drops. Methods: Fifty-six eyes of 28 patients with moderate keratoconjunctivitis sicca (DEWS severity level 2) were enrolled in the trial. Patients were randomized for 2 treatment groups (SYSTANE UD eye drops vs. Visine INTENSIV 1% EDO eye drops). The eye drops in both groups were applied 5 times per day for 3 months. Statistical analyses were performed using Statistica™ software (Mann–Whitney U-test and Wilcoxon test). P-Values

Friedrich E. Kruse - One of the best experts on this subject based on the ideXlab platform.

  • prospective randomized controlled comparison of systane ud eye drops versus Visine intensiv 1 edo eye drops for the treatment of moderate dry eye
    Journal of Ocular Pharmacology and Therapeutics, 2012
    Co-Authors: C. Jacobi, Friedrich E. Kruse, Claus Cursiefen
    Abstract:

    Abstract Purpose: The aim of this prospective, randomized, clinical, single-center study was to compare the safety and efficacy of 2 ocular surface lubricant eye drops: preservative-free hydroxypropyl (HP)-Guar (SYSTANE UD®) eye drops versus preservative-free Tamarindus indica seed polysaccharide (TSP) 1% (Visine INTENSIV 1% EDO®) eye drops. Methods: Fifty-six eyes of 28 patients with moderate keratoconjunctivitis sicca (DEWS severity level 2) were enrolled in the trial. Patients were randomized for 2 treatment groups (SYSTANE UD eye drops vs. Visine INTENSIV 1% EDO eye drops). The eye drops in both groups were applied 5 times per day for 3 months. Statistical analyses were performed using Statistica™ software (Mann–Whitney U-test and Wilcoxon test). P-Values<0.05 were considered significant. Results: After 3 months of treatment the patients of both groups had subjective benefit in the relief of symptoms of dry eye disease evaluated by the Ocular Surface Disease Index (OSDI) questionnaire score. Patients ...

  • Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus Visine INTENSIV 1% EDO eye drops for the treatment of moderate dry eye.
    Journal of Ocular Pharmacology and Therapeutics, 2012
    Co-Authors: C. Jacobi, Friedrich E. Kruse, Claus Cursiefen
    Abstract:

    Abstract Purpose: The aim of this prospective, randomized, clinical, single-center study was to compare the safety and efficacy of 2 ocular surface lubricant eye drops: preservative-free hydroxypropyl (HP)-Guar (SYSTANE UD®) eye drops versus preservative-free Tamarindus indica seed polysaccharide (TSP) 1% (Visine INTENSIV 1% EDO®) eye drops. Methods: Fifty-six eyes of 28 patients with moderate keratoconjunctivitis sicca (DEWS severity level 2) were enrolled in the trial. Patients were randomized for 2 treatment groups (SYSTANE UD eye drops vs. Visine INTENSIV 1% EDO eye drops). The eye drops in both groups were applied 5 times per day for 3 months. Statistical analyses were performed using Statistica™ software (Mann–Whitney U-test and Wilcoxon test). P-Values

Randy H. Kardon - One of the best experts on this subject based on the ideXlab platform.

  • Patient use of Visine (tetrahydrozoline) masks Horner syndrome
    British Journal of Ophthalmology, 2007
    Co-Authors: Michael S. Lee, Andrew R. Harrison, Randy H. Kardon
    Abstract:

    Horner syndrome may indicate a serious disorder such as carotid dissection, Pancoast tumour or medullary infarction. Autonomic headache syndromes such as cluster headache and hemicrania continua may also cause Horner syndrome.1 Absence of ptosis and pupillary miosis may delay the diagnosis and lead to grave consequences. We present a patient with painful Horner syndrome initially masked by Visine (tetrahydrozoline) use. A 46-year-old man developed sudden-onset, severe right periorbital aching for 8 weeks. The pain was constant with intermittent exacerbations. He noted ptosis of the right upper lid and red eye for 1 week. He subsequently used Visine (tetrahydrozoline HCl 0.05%) several times daily in …

Mateo Resetar - One of the best experts on this subject based on the ideXlab platform.

Related terms

Visine - 15 days free trial to Access Experts & Abstracts